University of Notre Dame du Lac’s Medicines Co MDCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-165,687
| Closed | -$14.1M | – | 64 |
|
|
2019
Q4 | $14.1M | Sell |
165,687
-100,382
| -38% | -$6.69M | 4.45% | 3 |
|
|
2019
Q3 | $13.3M | Sell |
266,069
-3,651
| -1% | -$146K | 3.97% | 4 |
|
|
2019
Q2 | $9.84M | Buy |
269,720
+162,168
| +151% | +$5.29M | 2.23% | 11 |
|
|
2019
Q1 | $3.01M | Sell |
107,552
-3,900
| -3% | -$91.9K | 0.67% | 45 |
|
|
2018
Q4 | $2.13M | Sell |
111,452
-186,407
| -63% | -$4.34M | 0.52% | 58 |
|
|
2018
Q3 | $8.91M | Buy |
297,859
+212,277
| +248% | +$8M | 1.66% | 32 |
|
|
2018
Q2 | $3.14M | Buy |
85,582
+3,355
| +4% | +$109K | 0.61% | 49 |
|
|
2018
Q1 | $2.71M | Sell |
82,227
-229,839
| -74% | -$7.18M | 0.5% | 60 |
|
|
2017
Q4 | $8.53M | Buy |
312,066
+119,515
| +62% | +$3.68M | 1.77% | 12 |
|
|
2017
Q3 | $7.13M | Buy |
192,551
+50,655
| +36% | +$1.87M | 1.99% | 10 |
|
|
2017
Q2 | $5.39M | Buy |
141,896
+91,836
| +183% | +$4.09M | 1.59% | 9 |
|
|
2017
Q1 | $2.45M | Sell |
50,060
-79,878
| -61% | -$3.64M | 0.61% | 61 |
|
|
2016
Q4 | $4.41M | Buy |
129,938
+71,838
| +124% | +$2.55M | 1.77% | 40 |
|
|
2016
Q3 | $2.19M | Buy |
58,100
+2,261
| +4% | +$85.2K | 1.9% | 24 |
|
|
2016
Q2 | $1.88M | Buy |
55,839
+11,776
| +27% | +$415K | 1.77% | 33 |
|
|
2016
Q1 | $1.4M | Buy |
44,063
+18,969
| +76% | +$620K | 1.72% | 36 |
|
|
2015
Q4 | $937K | Buy |
+25,094
| New | +$948K | 0.87% | 38 |
|
Other funds holding MDCO
University of Notre Dame du Lac's MDCO Position: Q1 2020 in Review
University of Notre Dame du Lac sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 165,687 shares — an estimated $14.1M sold.
University of Notre Dame du Lac first reported a position in MDCO in Q4 2015 and held it in 17 quarters. The position peaked at $14.1M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.
- University of Notre Dame du Lac reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
- University of Notre Dame du Lac sold 165,687 Medicines Co shares in Q1 2020, an estimated $14.1M.
- University of Notre Dame du Lac first reported a position in Medicines Co in Q4 2015 and held it in 17 quarters.
- University of Notre Dame du Lac's Medicines Co position peaked at $14.1M in Q4 2019.
- 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.
Based on University of Notre Dame du Lac's 13F filing for Q1 2020, filed 15 May 2020.